Mette Hintsteiner

Health Technology

Profile

Mette Hintsteiner held positions as Principal at H.
Lundbeck A and Bavarian Nordic A, Vice President-Engineering, Operations & Support at AGC Biologics A, and Principal at Xellia Pharmaceuticals ApS.

Former positions of Mette Hintsteiner

Companies	Position	End
Xellia Pharmaceuticals ApS Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark.	Corporate Officer/Principal	-
H. LUNDBECK A/S	Corporate Officer/Principal	-
BAVARIAN NORDIC A/S	Corporate Officer/Principal	-
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.	Chief Tech/Sci/R&D Officer	-

See the detail of Mette Hintsteiner's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies